Marshall Financial Group (Pennsylvania)’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-594
| Closed | -$4.68K | – | 58 |
|
|
2023
Q4 | $4.68K | Hold |
594
| – | – | ﹤0.01% | 53 |
|
|
2023
Q3 | $2.62K | Hold |
594
| – | – | ﹤0.01% | 48 |
|
|
2023
Q2 | $20.7K | Hold |
594
| – | – | 0.01% | 50 |
|
|
2023
Q1 | $12.9K | Hold |
594
| – | – | 0.01% | 51 |
|
|
2022
Q4 | $12.8K | Hold |
594
| – | – | 0.01% | 51 |
|
|
2022
Q3 | $14K | Hold |
594
| – | – | 0.01% | 53 |
|
|
2022
Q2 | $12K | Hold |
594
| – | – | 0.01% | 54 |
|
|
2022
Q1 | $21K | Hold |
594
| – | – | 0.01% | 57 |
|
|
2021
Q4 | $16K | Hold |
594
| – | – | 0.01% | 59 |
|
|
2021
Q3 | $26K | Hold |
594
| – | – | 0.01% | 60 |
|
|
2021
Q2 | $30K | Hold |
594
| – | – | 0.01% | 58 |
|
|
2021
Q1 | $27K | Hold |
594
| – | – | 0.01% | 56 |
|
|
2020
Q4 | $15K | Hold |
594
| – | – | 0.01% | 56 |
|
|
2020
Q3 | $9K | Buy |
+594
| New | +$9K | 0.01% | 53 |
|
|
2019
Q1 | – | Sell |
-94
| Closed | -$8K | – | 52 |
|
|
2018
Q4 | $8K | Buy |
+94
| New | +$8K | 0.01% | 51 |
|